178 related articles for article (PubMed ID: 19957325)
1. Underutilization of radiotherapy for lung cancer in New South Wales, Australia.
Vinod SK; Simonella L; Goldsbury D; Delaney GP; Armstrong B; O'Connell DL
Cancer; 2010 Feb; 116(3):686-94. PubMed ID: 19957325
[TBL] [Abstract][Full Text] [Related]
2. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
[TBL] [Abstract][Full Text] [Related]
3. High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL.
Pijls-Johannesma M; Houben R; Boersma L; Grutters J; Seghers K; Lambin P; Wanders R; De Ruysscher D
Radiother Oncol; 2009 Jun; 91(3):443-8. PubMed ID: 19297049
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
5. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
6. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
Kawaguchi T; Matsumura A; Iuchi K; Ishikawa S; Maeda H; Fukai S; Komatsu H; Kawahara M
Jpn J Clin Oncol; 2006 Jan; 36(1):7-11. PubMed ID: 16368713
[TBL] [Abstract][Full Text] [Related]
7. Palliative thoracic radiotherapy for lung cancer.
Kepka L; Olszyna-Serementa M
Expert Rev Anticancer Ther; 2010 Apr; 10(4):559-69. PubMed ID: 20397921
[TBL] [Abstract][Full Text] [Related]
8. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
9. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
Richardson GE; Thursfield VJ; Giles GG
Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
[TBL] [Abstract][Full Text] [Related]
10. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
Maas KW; El Sharouni SY; Smit EF; Schramel FM
Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176
[TBL] [Abstract][Full Text] [Related]
11. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
Barton MB; Gabriel GS; Miles S
ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
[TBL] [Abstract][Full Text] [Related]
13. Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy.
Graham PH; Clark C; Abell F; Browne L; Capp A; Clingan P; De Sousa P; Fox C; Links M
Australas Radiol; 2006 Aug; 50(4):342-8. PubMed ID: 16884421
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy patterns of care study in lung carcinoma.
Movsas B; Moughan J; Komaki R; Choy H; Byhardt R; Langer C; Goldberg M; Graham M; Ettinger D; Johnstone D; Abrams R; Munden R; Starkschall G; Owen J
J Clin Oncol; 2003 Dec; 21(24):4553-9. PubMed ID: 14597743
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in chemotherapy for lung cancer.
Lilenbaum RC
Curr Opin Pulm Med; 1996 Jul; 2(4):285-9. PubMed ID: 9363153
[TBL] [Abstract][Full Text] [Related]
16. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer.
Cakir S; Egehan I
Lung Cancer; 2004 Mar; 43(3):309-16. PubMed ID: 15165089
[TBL] [Abstract][Full Text] [Related]
17. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
Wang WH; Bao Y; Chen M; Zhang L; Li KX; Xu GC; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
19. Clinical patterns and treatment outcome of elderly patients in clinical stage IB/II non-small cell lung cancer.
Okamoto T; Maruyama R; Shoji F; Ikeda J; Miyamoto T; Nakamura T; Asoh H; Ichinose Y
J Surg Oncol; 2004 Sep; 87(3):134-8. PubMed ID: 15334641
[TBL] [Abstract][Full Text] [Related]
20. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.
El Sharouni SY; Kal HB; Barten-Van Rijbroek A; Struikmans H; Battermann JJ; Schramel FM
Anticancer Res; 2009 Dec; 29(12):5219-24. PubMed ID: 20044639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]